Category:
Chiral Intermediates
CAS NO:
486460-32-6
Standard:
ChP,
Sitagliptin is a novel anti-type 2 diabetes drug.
Its mechanism of action is different from previous oral hypoglycemic agents. It improves the blood sugar level of diabetic patients by increasing the ability of insulin cells to produce insulin in their own islet β cells and increasing insulin secretion when blood sugar is elevated.
MF: C16H15F6N5O
MW: 407.318418